Evaluation of the Effectiveness of the Use of the Therapeutic Bandage Method in Third Molar Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03393533 |
|
Recruitment Status :
Completed
First Posted : January 8, 2018
Last Update Posted : October 10, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pain | Procedure: Group I Procedure: Group II | Not Applicable |
Extraction of third molars is the procedure of oral and maxillofacial surgery most commonly performed around the world, usually at the outpatient level. Its execution may result in the appearance of reversible and / or irreversible disorders, but the most observed signs and symptoms are pain, edema and trismus to a greater or lesser degree. Thus, there seems to be no consensus within the literature for a better type of post-surgical treatment that leads to less patient discomfort when undergoing this kind of surgery.
The objective of this randomized, blinded trial will be to evaluate the use of therapeutic bandaging, Therapy Tex ©, In reducing the signs and symptoms inherent to the postoperative period of the third molar extracts, semi-included or included .
The sample will consist of 32 lower third molars, semi-inclusively or included, divided into two groups simultaneously, namely:
Group I (16 teeth) - without therapeutic bandaging on face. Group II (16 teeth) - with therapeutic bandaging on face. The therapeutic bandaging method will be applied in the patients of group II, according to the previous randomization.The bandage will be applied immediately after surgery and before the end of the anesthetic effect. The skin should be cleaned with 70% alcohol in order to remove residue and oiliness, and then should be dried. If necessary, scrape the hairs of the region in which the tape will rest. The application of the bandage will be in the proposed regions using the "I" cutout, in which no additional trimming is made on the tape. The length may vary depending on the size of the patient's face. After being applied the bandage should be gently wiped to activate the acrylic components that generate adhesiveness and should remain on the face for 3 days.
The patient is asked to occlude, the dimension of the masseter muscle is determined by palpation. During palpation, point A is selected in the lower portion of the zygomatic arch and point B is close to the angle of the mandible. The tape will be placed along the direction of the muscle fibers.
Placement of the second tape will occur from the mandibular angle to the mental symphysis, accompanying the entire mandibular body in its medial portion covering the milo-hyoid muscles and the anterior belly of the digastric.
The results of the clinical evaluations will be submitted to descriptive statistics and compared by means of the statistical analysis of variance (ANOVA) and Tukey test with significance level of 5%.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 7 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The sample will consist of 32 lower third molars, semi-inclusively or included. This study will be a randomized, blind, controlled, split-mouth clinical trial, divided into two groups simultaneously, namely: Group I (16 teeth) - without therapeutic banding on the face, after the third molar extraction. Group II (16 teeth) - with therapeutic banding on the face, after the third molar extraction. |
| Masking: | Single (Care Provider) |
| Masking Description: | Surgical procedures were always performed by the same surgeon and assistant, who was unaware of the group that belonged to the patient, as well as the patient himself. This randomization was performed involving numbers and envelopes, being only the investigator's knowledge. |
| Primary Purpose: | Treatment |
| Official Title: | Evaluation of the Effectiveness of the Use of the Therapeutic Bandage Method in Third Molar Surgery. Splint-mouth Randomized Blind Controlled Clinical Trial |
| Actual Study Start Date : | October 20, 2017 |
| Actual Primary Completion Date : | July 4, 2018 |
| Actual Study Completion Date : | August 4, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Group I
Extraction third molar with pre and postoperative evaluation of edema, pain and trismus
|
Procedure: Group II
Extraction third molar with the application of therapeutic bandaging in the face and with evaluation of edema, pain and trismus |
|
Active Comparator: Group II
Extraction third molar with therapeutic bandage pre and postoperative evaluation of edema, pain and trismus
|
Procedure: Group I
Extraction third molar without the application of therapeutic bandaging in the face and with evaluation of edema, pain and trismus |
- Pain assessment [ Time Frame: The scale will be provided on paper and divided into postoperative hours up to 3 days for the patient to note the degree of pain that varies between zero and ten ]Evaluated in patients in groups I and II. Scale of vas, with values from zero to ten, being zero without pain and ten the maximum of pain. This scale will be provided on paper and divided into postoperative hours up to 3 days.
- Edema assessment with a millimeter rule. [ Time Frame: For investigators to measure facial edema, with pre and postoperative evaluations of 3 and 7 days ]Evaluated in patients in groups I and II. Used the method of Ustün et al. (2003) with a millimeter rule to obtain the measures.
- Trismus assessment with a millimeter rule. [ Time Frame: To measure the buccal opening, the distance between the incisal edges of the maxillary and mandibular incisors, obtained with the patient sitting upright. Evaluated in the pre and postoperative periods of 3 and 7 days ]Evaluated in patients in groups I and II
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 15 Years to 40 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients with need for extraction of third molars, regardless of gender;
- Teeth in opposite hemiarches with similar positions;
- Between 15 and 40 years of age;
- That they agree to participate in the research voluntarily.
Exclusion Criteria:
- Patients presenting with local or systemic alterations that contraindicate the procedure;
- Use of anti-inflammatories in the last 15 days;
- Third lower third molars in position and different inclusion classification on both sides;
- Third erupted lower third molars.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03393533
| Brazil | |
| Michelle Bianchi de Moraes | |
| São José dos Campos, SP, Brazil, 12245000 | |
| Principal Investigator: | Michelle B Moraes, PHD | Universidade Estadual Paulista Júlio de Mesquita Filho |
| Responsible Party: | Michelle Bianchi de Moraes, Assistant Professor, Department of Diagnosis and Surgery, São Paulo State University (Unesp), Institute of Science and Technology, São José dos Campos, Brazil., Universidade Estadual Paulista Júlio de Mesquita Filho |
| ClinicalTrials.gov Identifier: | NCT03393533 |
| Other Study ID Numbers: |
Unesp |
| First Posted: | January 8, 2018 Key Record Dates |
| Last Update Posted: | October 10, 2018 |
| Last Verified: | October 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Third molar; Oral surgery; Pain; Edema; Trismus. |

